Fischer Medical Ventures Ltd.

Financial

	Fischer Medical	Chemplast Sanmar	GHCL
Operational Metrics
Financials
5 yr Average ROE	39.11 %	-14.92 %	21.5 %
5yr average Equity Multiplier	-0.03	0.34	1.42
5yr Average Asset Turnover Ratio	0.32	0.81	0.78
5yr Avg Net Profit Margin	-3.86 %	3.66 %	19.59 %
Price to Book	18.37	3.26	1.62
P/E	0.0	0.0	9.14
5yr Avg Cash Conversion Cycle	254.2 Days	-160.25 Days	23.8 Days
Inventory Days	25.95 Days	44.16 Days	79.76 Days
Days Receivable	200.41 Days	14.51 Days	20.09 Days
Days Payable	8.02 Days	204.35 Days	78.33 Days
5yr Average Interest Coverage Ratio	3.82	1.57	29.25
5yr Avg ROCE	20.39 %	15.83 %	22.74 %
5yr Avg Operating Profit Margin	5.78 %	12.16 %	26.94 %
5 yr average Debt to Equity	-1.28	-0.52	0.15
5yr CAGR Net Profit	n/a	n/a	13.86 %
5yr Average Return on Assets	-161.47 %	3.8 %	15.72 %
Shareholdings
Promoter Holding	61.8 %	54.99 %	18.97 %
Share Pledged by Promoters	0.0	0.0	1.1 %
Change in Promoter Holding (3 Yrs)	61.8 %	0.0	-0.06 %
Change in Mutual Fund Holding (3 Yrs)	0.0	-0.11 %	-3.79 %

Business

	Fischer Medical	Chemplast Sanmar	GHCL
Product Wise Break-Up	Product Wise Break-Up Chemicals 100.0 0 Soda Ash 0 Consumer products 0	-	Product Wise Break-Up Consumer Durable 2.17 0 Soda Ash 97.83 Chemicals 0